Aimmune Therapeutics

Aimmune Therapeutics

Aimmune Therapeutics

Aimmune Therapeutics is a clinicalstage biopharmaceutical company developing desensitization treatments to protect people with food allergies from the lifethreatening consequences of accidental exposures to their allergens.
Founded
2011
Follow us
Alexa global traffic share
Team Size
10+
Employees
Business Insider , Pulse 2.0

Aimmune Therapeutics soars 172% after Nestle agrees to acquire the peanut allergy treatment company for $2.6 billion (AI...

Xconomy

Aimmune May Seek Up To $115M in IPO for Allergy Therapy Drug

Health